Rheumatoid Foot Insole
Effect of Rheumatoid Foot Insole
1 other identifier
interventional
80
1 country
1
Brief Summary
The present study aims to evaluate the effect of insoles for foot arthritis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable rheumatoid-arthritis
Started Nov 2011
Shorter than P25 for not_applicable rheumatoid-arthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2011
CompletedFirst Submitted
Initial submission to the registry
March 2, 2012
CompletedFirst Posted
Study publicly available on registry
March 7, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2012
CompletedMarch 9, 2012
March 1, 2012
1 year
March 2, 2012
March 8, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual analog scale of pain in feet during walking (VAS)
Assessing pain in the feet during walking through a visual analog scale from 0 to 10 centimeter (cm)
12 months
Secondary Outcomes (9)
Foot Function Index (FFI)
12 months
Foot Health Status Questionnaire (FHSQ-Br)
12 months
Health Assessmente Questionnaire (HAQ)
12 months
Visual analog scale of pain in feet at rest (VAS)
12 months
6-MINUTE WALK TEST
12 months
- +4 more secondary outcomes
Study Arms (2)
intervention foot orthoses
EXPERIMENTALEthyl vinyl acetate (EVA) insole with medial arch support and bar retrocapital
placebo insole
PLACEBO COMPARATORFoot orthose with support retrocapital and support of medial arch insole intervention
Interventions
EVA insole with arch support and bar retrocapital
Eligibility Criteria
You may qualify if:
- Patients with established diagnosis RA according to criteria of the American College of Rheumatology (ACR) functional classes I, II and III
- Foot pain with VAS between 3 - 8 cm for walking
- Age 18-65 years
- Basic medication stable for at least three months
- Not made infiltrations in feet and ankles in the last three months and not during the study
- Agreed to participate and signed term of informed consent
You may not qualify if:
- Other musculoskeletal disorders in symptomatic lower limbs
- Diseases of the central and peripheral nervous system
- Decompensated diabetes mellitus
- No walking
- Rigid deformities in the feet
- Use of insoles in the last three months
- Surgery scheduled in the next 12 months
- Allergy to the material
- Mental deficiency
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Emilia Moreira
São Paulo, São Paulo, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
EMILIA MOREIRA, PT
Federal University of São Paulo
- STUDY DIRECTOR
ANAMARIA PT JONES, PHD
Federal University of São Paulo
- STUDY CHAIR
JAMIL NATOUR, PHD
Division of Rheumatology, Federal University of Sao Paulo
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Effect of rheumatoid foot insole
Study Record Dates
First Submitted
March 2, 2012
First Posted
March 7, 2012
Study Start
November 1, 2011
Primary Completion
November 1, 2012
Study Completion
November 1, 2012
Last Updated
March 9, 2012
Record last verified: 2012-03